---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-021705"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T01:50:10.642569+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q2 revenue $6.2M, down 32% YoY; net loss $5.2M; cash $35.1M

## Summary
- Revenue $6.2M vs $9.1M YoY; system revenue $0.6M, recurring $5.6M.
- Net loss $5.2M; prior-year net loss $1.2M included $2.2M PPP loan forgiveness.
- Adjusted net loss (excl. stock comp) $2.5M; operating expenses $9.8M.
- Cash $35.1M, no debt; expects year-end cash ~$32M; no additional financing needed.
- Backlog over $12M supports 2022 revenue growth guidance; cautious on hospital construction timelines.

## SEC filing metadata
- accession: 0001493152-22-021705
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315222021705/0001493152-22-021705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315222021705/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-021705
- JSON: https://secwatch.observer/filing/0001493152-22-021705.json
- Plain text: https://secwatch.observer/filing/0001493152-22-021705.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.